معرفی
Annika Lindblom is a Senior Professor at Karolinska Institutet, affiliated with the Department of Molecular Medicine and Surgery and the Clinical Genetics research group under Richard Rosenquist Brandell. Her academic career includes roles as a Docent (since 1996) and Professor (since 2020).
Education & Roles: She holds a Docent title from Karolinska Institutet and has led numerous research projects focused on cancer genetics and hereditary syndromes. She supervises doctoral students, such as Petri Rantanen, and contributes to clinical and translational research in oncology.
Research Interests: Her work centers on genetic predisposition to cancer, particularly colorectal and breast cancers, Lynch syndrome, and the interplay between genetics and lifestyle factors. Key areas include identifying genetic modifiers, risk stratification, and preventive strategies through genomic studies and clinical trials.
Publications: Lindblom's research spans over 300 publications, with recent work highlighting genetic associations in Lynch syndrome, colorectal cancer risk factors, and polygenic risk scores. Her studies often involve large-scale collaborations, such as the Prospective Lynch Syndrome Database.
Grants & Funding: She has secured funding from the Swedish Research Council, Swedish Cancer Society, and others for projects on cancer prevention, genetic testing strategies, and Lynch syndrome management. Notable grants include studies on mesalamine for colorectal cancer prevention and genetic risk assessment in hereditary cancers.
Labs/Teams: She leads the Clinical Genetics research group, focusing on translational research and clinical applications of genetic discoveries. Her work bridges molecular genetics and clinical oncology to improve patient outcomes.
